Cambridge Universities Development Plans 2016 **SOLD OUT**

 

THREE of Cambridge’s leading university heads will be presenting their investment/development plans for the next few years!

 

 

 

 

 

Event Sponsored by:                                Programme Sponsored by: 

              

---

Event Format

• 1530 – 1600; Registration
• 1600 – 1645; Networking with Wine, Beer and Soft Drinks
• 1645 – 1815; Speaker Presentations
• 1815 – 1900; Networking with Hot Food, Wine, Beer and Soft Drinks
• 1930 – 2200; After Event Speakers Dinner (VIP TICKET HOLDERS ONLY) **SOLD OUT**

---

New VIP Tickets

We have an exciting new opportunity for you – buy a VIP ticket to this event and come to dinner straight after the event with the speakers who have accepted an invitation, see below.

Great food, good wine and excellent conversation.

VIP Ticket Privileges

• FREE attendance at Speakers Dinner
• Reserved seating in the front two rows at the event
• Guaranteed tickets at Sold-Out events
• Only 15 VIP Tickets available at each event
• VIP Name Badges
• Maximum two VIP Tickets per Company

Restaurant 22 **SOLD OUT**

 

 

 

 

 

Come to dinner and join:

• Professor Nigel Slater – University of Cambridge
• Dr Keith Carne – King’s College, Cambridge
• Deborah Griffin – Homerton College

---

Speakers

---

Professor Nigel Slater, Pro-Vice Chancellor for Enterprise & the Region; University of Cambridge

I am Pro-Vice-Chancellor (Enterprise and Region) and a Professor in the Department of Chemical Engineering and Biotechnology in the University of Cambridge.

My career has been in bioprocessing research and practice and I have held positions in both industry and academia. At Cambridge my research group investigates new ways to make and stabilise bio-pharmaceutical products including proteins, DNA, viruses and cells. I have been PI of over 70 significant bioprocessing research projects that have been funded by government and by industry. At the Wellcome Research Laboratories I led process development for the Campath-1H monoclonal antibody through to pivotal clinical testing and as a principal of Cobra Therapeutics I was involved with the process development for a GDEPT retrovirus gene therapy vector through to Phase 2 clinical testing.

I was a Non-Executive Director of Cobra Bio-Manufacturing PLC from its IPO on AIM in 2002 until its acquisition in 2010, and a principal of Angel Technology Ltd, a nutri-food company that won the Queen’s Award for Innovation 2006 and the International Sial d’Or Prize for the most innovative new UK nutritional product at the Paris International Food Conference 2004.

---

Dr Keith Carne, First Bursar; King’s College Cambridge

I am the First Bursar at King’s College and was nominated to the Audit Committee by the Bursars’ Committee. I find the Audit Committee both interesting and important because of its role in overseeing the efficient operation of the University, including the interaction of the Colleges with the central University.

Before being appointed as Bursar at King’s I was a lecturer in the Department of Pure Mathematics. My chief research concerns were in geometric complex analysis and probability theory.

---

Deborah Griffin, Bursar; Homerton College, Cambridge

After taking a degree in Economics at UCL, Deborah qualified as a Chartered Accountant and worked in the hotel industry before joining Andersen and then Deloittes where she has been working  in corporate finance.

Deborah has been involved with women’s rugby since the late 1970s.   She currently represents women’s and girls’ rugby on the Council  of the Rugby Football Union (RFU) and is also a member of the Audit & Risk Committee and Community Game Board for the RFU.  Prior to the integration of the Rugby Football Union for Women (RFUW) with the RFU on July 1 2012, Deborah chaired the RFUW and now chairs the Integration Board.

---